The Lupus Forum

ACR 2024 Highlights: Day 1 by The Lupus Forum

ACR 2024 Highlights: Day 2 by The Lupus Forum

ACR 2024 Highlights: Day 3 by The Lupus Forum

Steering Committee members Professor Ed Vital, who is a Professor in Autoimmune Connective Tissue Diseases and Honorary Consultant Rheumatologist, at Leeds Teaching Hospitals NHS Trust, UK, is joined by Professor Richard Furie, who is Chief of the Division of Rheumatology at the Department of Medicine, Northwell Health, New York, and Professor of Medicine at the Zucker School of Medicine at Hofstr...

Steering Committee members Professor Chris Edwards from the University Hospital Southampton NHS Foundation Trust is joined by Professor Victoria Werth, from the Philadelphia Veterans Administration Hospital, Pennsylvania, USA on the latest Lupus Forum podcast. Together, they discuss the efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients wit...

Join Professors Ed Vital, Vibeke Strand, Laurent Arnaud, and Guillermo Pons-Estel as they unpack the key challenges of inequities of outcomes in lupus treatment. Providing an overview of social determinants of health in SLE, the impact of race and ancestry, and controlling disease in low and middle income country populations. You can view this video on our website here: https://lupus-forum.com/exp...

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Doctor Antony Psarras, an NIHR Academic Clinical Lecturer in Rheumatology at the University of Oxford and at the Kennedy Institute of Rheumatology. Together, they discuss the use of CD163 as a marker for diagnosis and flare in lupus nephritis. They also discuss the impact of discontinuing immunosuppression on the disease, in pa...

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Professor Vibeke Strand, Adjunct Clinical Professor at the Division of Immunology and Rheumatology at Stanford University School of Medicine in California. Together, they discuss the efficacy and safety of upadacitinib and elsubrutinib combination and monotherapy, as well as the association of LLDAS with improved outcomes in SL...

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Professor Vibeke Strand, Adjunct Clinical Professor at the Division of Immunology and Rheumatology at Stanford University School of Medicine in California. Together, they discuss predictors of belimumab renal response in lupus nephritis, and the efficacy and safety of telitacicept in SLE with haematological involvement.

Join Professors Ed Vital, Richard Furie, Vibeke Strand, and Brad Rovin as they unpack the modern world of lupus clinical trials; their challenges and the potential solutions.

With the continued release of new treatment data in lupus this podcast will highlight the key data presented at EULAR 2024. Together, our faculty discuss the latest data on CAR-T cells, rituximab, deucravacitinib, and so much more.

Join Professor Ed Vital as he goes through our top abstracts, posters, and presentations from Day 4 of EULAR 2024 today (Saturday 15 June). They're all available right here on the Lupus Forum YouTube channel, so make sure you don't miss them!

Join Professor Ed Vital as he goes through our top abstracts, posters, and presentations from Day 3 of EULAR 2024 today (Friday 14 June). They're all available right here on the Lupus Forum YouTube channel, so make sure you don't miss them!

Join Professor Ed Vital as he goes through our top abstracts, posters, and presentations from Day 2 of EULAR 2024 today (Thursday 13 June). They're all available right here on the Lupus Forum YouTube channel, so make sure you don't miss them!

Join Professor Ed Vital as he goes through our top abstracts, posters, and presentations from Day 1 of EULAR 2024 today (Wednesday 12 June). They're all available right here on the Lupus Forum YouTube channel, so make sure you don't miss them!

Join Professors Ed Vital and Chris Edwards as they preview our highlights this EULAR, introducing some of the top abstracts and posters we’ve chosen so that you can better plan your time at what will be a busy and exciting congress.

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Professor Brad Rovin, Professor of Nephrology and Medical Director of the Ohio State University Clinical Research Management Institute. Together, they discuss the use of belimumab to reduce prednisone doses and the development of the SLESIS-R score for determining the risk of severe infection in SLE.

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Professor Victoria Werth, Professor of Dermatology and Medicine, University of Pennsylvania and Philadelphia Veterans Administration Hospital. Together, they discuss the latest developments in CAR T-cell therapy, development of Smith-specific regulatory T cells, and cardiovascular risk factors.

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Professor Chris Edwards, Consultant Rheumatologist and Honorary Chair of Clinical Rheumatology University Hospital Southampton, UK. Together, they discuss the latest developments and perspectives in glucocorticoid tapering, TYK2 therapy in rheumatic disease, as well as SLE QoL and LLDAS.

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Professor Maria Dall’Era, Professor of Medicine and Chief of the Division of Rheumatology at the University of California in San Francisco, USA. Together, they discuss latest developments and perspectives in RNase therapy and patient-reported outcome quality measures in SLE, as well as serological predictors of renal flares. Lu...

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Vibeke Strand, Adjunct Clinical Professor of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California. Together, they discuss the latest developments and perspectives in telitacicept therapy, fatigue, and disease burden.

Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Dr Chi Chiu Mok, Chief of the Division of Rheumatology at Tuen Mun Hospital in Hong Kong. Together, they discuss the ability of obinutuzumab to preserve kidney function in patients with lupus nephritis, real-world data for telitacicept therapy, and the relationship between HCQ nonadherence and SLE disease flares.

Join Ed Vital, from the University of Leeds, and Chair of the Lupus Forum, along with Professor Vibeke Strand, Adjunct Clinical Professor of Immunology and Rheumatology at Stanford University School of Medicine in Palo Alto, California as they discuss the impact of the recent EULAR 2023 recommendations for SLE including LN, emerging therapies for CLE and real-world data for anifrolumab.

With the continued release of new treatment data in lupus this podcast will highlight the key data presented at ACR 2023. Together our faculty discuss the latest data on CAR-T cells, novel JAK inhibitors, and much much more from ACR 2023.

Join Professor Ed Vital as he goes through our top abstracts, posters, and presentations from Day 4 of ACR 2023 today (Sunday 15 November). They're all available right here on the Lupus Forum YouTube channel, so make sure you don't miss them!